CERS Q3 2019 Earnings — Cerus Corporation Revenue & Financial Results | Market Cap Arena

CERSCerus Corporation

$335M

Q3 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$18M+17.0% YoY

Gross Profit

$10M57.9% margin

Operating Income

-$17M-94.1% margin

Net Income

-$18M-99.7% margin

EPS (Diluted)

$-0.13

QoQ Revenue Growth

-1.0%

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$24M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$164M

Total Liabilities

$104M

Stockholders' Equity

$61M

Cash & Equivalents

$24M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$18M	$15M	+17.0%
Gross Profit	$10M	$7M	+43.8%
Operating Income	-$17M	-$14M	-24.7%
Net Income	-$18M	-$14M	-26.6%

Revenue Segments

Product

$18M79%

Government Contract

$5M21%

Geographic Segments

Europe Middle East And Africa

$13M71%

North America

$5M27%

Other

$421,0002%